REGENXBIO, Inc. (RGNX)
6.125
+0.04
(+0.74%)
USD |
NASDAQ |
Jun 08, 16:00
6.125
0.00 (0.00%)
After-Hours: 19:35
REGENXBIO Total Assets (Quarterly) : 341.89M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocugen, Inc. | 56.90M |
| Capricor Therapeutics, Inc. | 326.28M |
| Krystal Biotech, Inc. | 1.397B |
| Biogen, Inc. | 29.48B |
| AbbVie, Inc. | 136.46B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 320.81M |
| Shareholders Equity (Quarterly) | 21.08M |
| Debt to Equity Ratio | 11.78 |
| Current Ratio | 2.623 |
| Net Debt Paydown Yield | -4.93% |